| 51 |
22401294 | Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells. | 2012 Mar 8 |
1 |
| 52 |
22476852 | Targeting of mTORC2 prevents cell migration and promotes apoptosis in breast cancer. | 2012 Aug |
1 |
| 53 |
22556409 | The PP242 mammalian target of rapamycin (mTOR) inhibitor activates extracellular signal-regulated kinase (ERK) in multiple myeloma cells via a target of rapamycin complex 1 (TORC1)/eukaryotic translation initiation factor 4E (eIF-4E)/RAF pathway and activation is a mechanism of resistance. | 2012 Jun 22 |
1 |
| 54 |
22566604 | Inhibition of the mTORC2 and chaperone pathways to treat leukemia. | 2012 Jun 21 |
1 |
| 55 |
22685175 | Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia. | 2012 Jul 26 |
2 |
| 56 |
23026799 | Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells. | 2012 Dec |
3 |
| 57 |
21615676 | Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells. | 2011 Oct |
2 |
| 58 |
20072130 | Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor. | 2010 Feb |
1 |
| 59 |
20227039 | Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E. | 2010 Mar 16 |
1 |
| 60 |
19209957 | Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. | 2009 Feb 10 |
2 |